GridAI Technologies (GRDX) Receivables - Accured (2020)
GridAI Technologies' (GRDX) quarterly Receivables - Accured came in at $551489.0 in Q4 2020.
Powered by 
Analysis
GridAI Technologies (GRDX) Receivables - Accured (2020) Analysis & Trends
GridAI Technologies (GRDX) has reported Receivables - Accured for 1 consecutive years, with $551489.0 the latest figure, recorded in Q4 2020.
- For the quarter ending Q4 2020, Receivables - Accured changed N/A year-over-year to $551489.0; the trailing twelve-month figure through Dec 2020 stood at $551489.0 (changed N/A YoY), and the FY2020 full-year result was $551489.0, changed N/A from the prior year.
- Receivables - Accured was little changed at $551489.0 in Q4 2020 per GRDX's latest filing.
- Across five years, Receivables - Accured topped out at $551489.0 in Q4 2020 and bottomed at $551489.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.73 Bn | 192.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.91 Bn | 176.73 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.33 Bn | 123.48 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.13 Bn | 74.13 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.36 Bn | 55.18 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.70 Bn | 48.56 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.05 Bn | 29.74 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.96 Bn | 30.67 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.27 Bn | 29.27 Bn | 1.16 Mn | 21.60 Mn |
| 10 | GridAI Technologies | 18.97 Mn | 18.97 Mn | -36,514.00 | - |